AQST Aquestive Therapeutics, Inc.

8-K Current Report

Filed: February 26, 2026

Health Care

Pharmaceutical Preparations

Aquestive Therapeutics, Inc. (AQST) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 7.01 · Regulation FD Disclosure

• Aquestive Therapeutics conducting institutional investor/analyst roadshow meetings
• Full presentation content in Exhibit 99.1 — key product pipeline and financial details located there

+1 more insights

Other Aquestive Therapeutics, Inc. 8-K Filings

8-K Mar 4, 2026

Get deeper insights on Aquestive Therapeutics, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.